Pfizer Inc’s (PFE.N) quarterly profit topped Wall Street forecasts, driven by stronger-than-expected sales of pneumonia vaccine Prevnar.The largest U.S. drugmaker said on Tuesday Prevnar recorded sales of $1.38 billion in the first quarter of 2018. Analysts on average had expected sales of $1.37 billion,
Pfizer’s net profit rose to $3.56 billion or 59 cents per share, from $3.12 billion or 51 cents per share a year earlier.
Total revenue rose 1 percent to $12.91 billion. Analysts had expected $13.13 billion.
Pfizer shares fell 0.9 percent to $36.28 in premarket trading on Tuesday.